CD274 and non-small cell lung carcinoma: In another retrospective study including 282 patients treated with immunotherapy, PD‐L1 expression seemed to be more relevant for predicting the efficacy of ICIs in KRAS‐mutant NSCLC than in wild‐type NSCLC.